Richard Walz - Gabelli Convertible Chief Compliance Officer
GCV Fund | USD 3.95 0.05 1.25% |
Mr. Richard J. Walz is a Chief Compliance Officer of The Gabelli Convertible and Income Securities Fund, Inc., he is Chief Compliance Officer of all the registered investment companies in the GabelliGAMCO Funds Complex since 2013 Chief Compliance Officer of AEGON USA Investment Management 20112013 Chief Compliance Officer of Cutwater Asset Management 20042011.
Age | 60 |
Tenure | 11 years |
Phone | 914-921-5000 |
Web | https://www.gabelli.com/Template/fundinfo.cfm?tid=ZTQ4&bid=NmU0Mw==&mid=ZmRjOA==&num=MzcyZjg=&kid=NjNhODI=&fid=MzU2ZDI=&rid=704=edoc_dnuf |
Gabelli Convertible Management Performance (%)
The company has Return on Asset of (0.1) % which means that on every $100 spent on assets, it lost $0.1. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (24.62) %, meaning that it generated no profit with money invested by stockholders. Gabelli Convertible's management efficiency ratios could be used to measure how well Gabelli Convertible manages its routine affairs as well as how well it operates its assets and liabilities.Similar Money Managers
Showing other executives | One Year Return | ||
Lucinda Stebbins | Tekla Healthcare Investors | 73 | |
Michael Castellano | Blackrock Enhanced Capital | 75 | |
Laura Woodward | Tekla Healthcare Investors | 51 | |
Valerie Mosley | Eaton Vance New | 59 | |
Cynthia Frost | Eaton Vance New | 58 | |
Jonathan Chirunga | Pioneer Municipal High | N/A | |
Cedric Antosiewicz | Nuveen New York | 58 | |
Frank Fabozzi | Blackrock Enhanced Capital | 73 | |
Lucinda Stebbins | Tekla Life Sciences | 73 | |
Cedric Antosiewicz | Nuveen Mortgage Opportunity | 57 | |
Dr MS | Tekla Healthcare Investors | 71 | |
William Reardon | Tekla Healthcare Investors | 74 | |
Helen Peters | Eaton Vance New | 71 | |
Susan Sutherland | Eaton Vance New | 62 | |
Charles Park | Blackrock Enhanced Capital | 54 | |
Janey Ahn | Blackrock Enhanced Capital | 46 | |
Rakesh Jain | Tekla Healthcare Investors | 69 | |
Rakesh Jain | Tekla Life Sciences | 69 | |
Jay Fife | Blackrock Enhanced Capital | 51 | |
Henry Gabbay | Blackrock Enhanced Capital | 72 | |
Jenna Bailey | Western Asset High | 42 |
Management Performance
Return On Equity | -24.62 | |||
Return On Asset | -0.1 |
Gabelli Convertible And Leadership Team
Elected by the shareholders, the Gabelli Convertible's board of directors comprises two types of representatives: Gabelli Convertible inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Gabelli. The board's role is to monitor Gabelli Convertible's management team and ensure that shareholders' interests are well served. Gabelli Convertible's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Gabelli Convertible's outside directors are responsible for providing unbiased perspectives on the board's policies.
Bruce Alpert, President Acting Chief Compliance Officer | ||
Dugald Fletcher, Independent Director | ||
Thomas Dinsmore, Independent Director | ||
Laurissa Martire, Vice President, Ombudsman | ||
Salvatore Zizza, Independent Director | ||
Kuni Nakamura, Independent Director | ||
Mario Gabelli, Chairman of the Board, Chief Investment Officer | ||
Anthony Pustorino, Lead Independent Director | ||
E Cerutti, Independent Director | ||
John Birch, Independent Director | ||
Michael Melarkey, Independent Director | ||
Leslie Foley, Independent Director | ||
Bethany Uhlein, Vice President, Ombudsman | ||
Vincent Enright, Independent Director | ||
Agnes Mullady, President of the Open-End Fund Division and COO of the Open-End Fund Division | ||
Peter Goldstein, Vice President Secretary | ||
Richard Walz, Chief Compliance Officer | ||
Daniel Plourde, Vice President | ||
Werner Roeder, Independent Director | ||
Andrea Mango, Vice President, Secretary | ||
Anthonie Ekris, Independent Director | ||
Daniel Harding, Independent Director | ||
Anthony Colavita, Independent Director | ||
John Ball, Treasurer and Prinicipal Financial and Accounting Officer |
Gabelli Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right fund is not an easy task. Is Gabelli Convertible a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -24.62 | |||
Return On Asset | -0.1 | |||
Operating Margin | (12.19) % | |||
Current Valuation | 129.15 M | |||
Shares Outstanding | 18.82 M | |||
Shares Owned By Insiders | 3.34 % | |||
Shares Owned By Institutions | 22.02 % | |||
Number Of Shares Shorted | 65.67 K | |||
Price To Earning | 3.39 X | |||
Price To Book | 0.78 X |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Gabelli Fund
Gabelli Convertible financial ratios help investors to determine whether Gabelli Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gabelli with respect to the benefits of owning Gabelli Convertible security.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |